Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On mammary stem cells.

Wendy A Woodward1, Mercy S Chen, Fariba Behbod

  • 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3498, USA.

Journal of Cell Science
|August 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

NPJ breast cancer·2026
Same author

CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs.

Nucleic acids research·2026
Same author

MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9<sup>+</sup> monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancer.

bioRxiv : the preprint server for biology·2026
Same author

Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ.

Breast cancer research : BCR·2026
Same author

Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.

Nature communications·2026
Same author

Semaphorin-7A promotes macrophage-mediated mammary epithelial and ductal carcinoma in situ invasion.

Breast cancer research : BCR·2025

Mammary gland stem cells are crucial for tissue regeneration and potentially drive breast cancer. Understanding their self-renewal pathways is key to developing targeted cancer therapies.

Area of Science:

  • * Stem Cell Biology
  • * Cancer Research
  • * Molecular Biology

Background:

  • * Mammary gland stem cells (MGSCs) are quiescent, self-renewing cells responsible for differentiated cell types in the mammary gland.
  • * MGSCs are implicated in the initiation and progression of various breast cancers.
  • * Identifying and understanding MGSCs is critical for effective breast cancer treatment.

Purpose of the Study:

  • * To review methods for identifying mammary gland stem cells.
  • * To explore key signaling pathways involved in MGSC self-renewal and fate.
  • * To highlight the importance of MGSCs in breast cancer etiology.

Main Methods:

  • * Mammosphere culture assays.
  • * 5-bromo-2-deoxyuridine (BrdU) label-retention studies.

Related Experiment Videos

  • * Cell-surface marker analysis (Sca1, CD49f) and Hoechst dye efflux.
  • * Characterization of Notch, Wnt, and Hedgehog signaling pathways.

    • Main Results:

    • * Multiple methods effectively identify and characterize mammary gland stem cells.
    • * Signaling pathways like Notch, Wnt, and Hedgehog play vital roles in MGSC self-renewal and differentiation.
    • * These pathways are potential therapeutic targets for eradicating cancer-initiating cells.

    Conclusions:

    • * Mammary gland stem cells are fundamental to mammary gland development and homeostasis.
    • * Dysregulation of MGSC self-renewal pathways may contribute to breast cancer development.
    • * Further research into MGSC biology is essential for advancing breast cancer therapies.